Alkermes Logo

Alkermes

🇮🇪
ALKS
IE00B56GVS15

Alkermes is an innovative pharmaceutical company headquartered in Ireland, specializing in the research, development, and commercialization of novel medicines. The company focuses on providing groundbreaking therapies for patients with complex neurological and psychiatric diseases. Alkermes drives global healthcare forward through scientific excellence to improve quality of life.

Next Quarterly Earnings

Wednesday, July 29, 2026
CW 31
Pre-Market
In 17 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Currently in quiet period until July 29, 2026

Stock Price

Frequently asked questions

When will Alkermes report its next quarterly earnings?

Alkermes is scheduled to report its next quarterly earnings on 07/29/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Alkermes last report quarterly earnings?

Alkermes last reported quarterly earnings on 5/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.40 USD.

How do I add the Alkermes earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.02
Actual:
Q2 2026
Beat
Estimate:-$0.55
Actual:-$0.40
Difference:+$0.15
Q1 2026
Missed
Estimate:$0.41
Actual:$0.29
Difference:-$0.12

Company Information

Name
Alkermes
Ticker Symbol
ALKS
ISIN
IE00B56GVS15
Country
🇮🇪
Ireland
Sector
Healthcare
More Financial Information